ATE239724T1 - Salz von naphthylidincarbonsäure-derivaten - Google Patents

Salz von naphthylidincarbonsäure-derivaten

Info

Publication number
ATE239724T1
ATE239724T1 AT98908300T AT98908300T ATE239724T1 AT E239724 T1 ATE239724 T1 AT E239724T1 AT 98908300 T AT98908300 T AT 98908300T AT 98908300 T AT98908300 T AT 98908300T AT E239724 T1 ATE239724 T1 AT E239724T1
Authority
AT
Austria
Prior art keywords
naphthylidine
salt
carboxylic acid
acid derivatives
derivatives
Prior art date
Application number
AT98908300T
Other languages
English (en)
Inventor
Ae Ri Kim
Jin Hwa Lee
Ki Sook Park
Jong Ryoo Choi
Tae Hee Lee
Jay Hyok Chang
Do Hyun Nam
Hoon Choi
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Application granted granted Critical
Publication of ATE239724T1 publication Critical patent/ATE239724T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98908300T 1997-03-21 1998-03-20 Salz von naphthylidincarbonsäure-derivaten ATE239724T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19970009840 1997-03-21
PCT/KR1998/000051 WO1998042705A1 (en) 1997-03-21 1998-03-20 Salt of naphthyridine carboxylic acid derivative

Publications (1)

Publication Number Publication Date
ATE239724T1 true ATE239724T1 (de) 2003-05-15

Family

ID=19500439

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01203507T ATE257836T1 (de) 1997-03-21 1998-03-20 Salz von naphthyridincarbonsäure-derivaten
AT98908300T ATE239724T1 (de) 1997-03-21 1998-03-20 Salz von naphthylidincarbonsäure-derivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01203507T ATE257836T1 (de) 1997-03-21 1998-03-20 Salz von naphthyridincarbonsäure-derivaten

Country Status (39)

Country Link
US (9) US7700617B2 (de)
EP (2) EP1179533B1 (de)
JP (3) JP3759962B2 (de)
KR (1) KR100266499B1 (de)
CN (1) CN1131229C (de)
AP (1) AP1331A (de)
AR (1) AR012125A1 (de)
AT (2) ATE257836T1 (de)
AU (1) AU726634B2 (de)
BG (1) BG63972B1 (de)
BR (1) BR9808290A (de)
CA (1) CA2283671C (de)
CZ (2) CZ288673B6 (de)
DE (2) DE69814378T2 (de)
DK (2) DK1179533T3 (de)
DZ (1) DZ2448A1 (de)
EA (1) EA001674B1 (de)
ES (2) ES2198697T3 (de)
HK (1) HK1026698A1 (de)
HU (2) HU225412B1 (de)
ID (1) ID22681A (de)
IL (2) IL131812A0 (de)
IN (1) IN188178B (de)
IS (2) IS2093B (de)
MA (1) MA24500A1 (de)
MY (1) MY137653A (de)
NO (1) NO312515B1 (de)
NZ (1) NZ337748A (de)
OA (1) OA11161A (de)
PE (1) PE67999A1 (de)
PL (1) PL191815B1 (de)
PT (2) PT981527E (de)
SA (1) SA98181055B1 (de)
SI (2) SI1179533T1 (de)
SK (1) SK284107B6 (de)
TR (1) TR199902313T2 (de)
UA (1) UA56218C2 (de)
WO (1) WO1998042705A1 (de)
ZA (1) ZA982335B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
SK13342001A3 (sk) * 1999-03-19 2002-04-04 Knoll Gmbh Použitie zlúčeniny a farmaceutická kompozícia ju obsahujúca
US6331550B1 (en) 1999-06-29 2001-12-18 Smithkline Beecham Corporation Methods of use of quinolone compounds against anaerobic pathogenic bacteria
US6262071B1 (en) 1999-06-29 2001-07-17 Smithkline Beecham Corporation Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria
US6803376B1 (en) 1999-06-29 2004-10-12 Smithkline Beecham Corporation Method of use of quinolone compounds against pneumococcal and haemophilus bacteria
CA2282066C (en) 1999-06-29 2010-09-07 Smithkline Beecham Corporation Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
JP2001097864A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 呼吸管および尿路病原性細菌に対するフルオロキノリン化合物の使用方法
JP2001097863A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 嫌気性病原菌に対するフルオロキノロン化合物の使用法
EP1561465A3 (de) * 1999-09-22 2005-12-21 LG Life Sciences, Ltd. Verfahren zur Verwendung von fluorochinolonen Verbindungen gegen Bakterien
GR1003520B (el) * 1999-09-22 2001-01-22 Smithkline Beecham Plc Μεθοδος χρησης ενωσεων φλουοροκινολονης εναντια σε νοσοκομειακα αρνητικα κατα gramμ παθογενων βακτηριδιων
JP2001097891A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 呼吸器系病原菌に対するフルオロキノロン化合物の使用法
GR1003521B (el) * 1999-09-23 2001-01-22 Smithkline Beecham Plc Μεθοδοι χρησεως ενωσεων φλουοροκινολονης εναντια κατα gram θετικων παθογονων βακτηριδιων
KR20010091379A (ko) * 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
SI1412078T1 (sl) 2001-08-02 2009-04-30 Lg Life Sciences Ltd Lg Twin T Postopki za pripravo amino-zaščitenih derivatov 4-aminometilen-pirolidin-3-ona, gemifloksacina ali njegove soli
MXPA04005179A (es) * 2001-11-30 2004-08-11 Lg Life Sciences Ltd Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y una antibiotico de (-lactama.
KR100517638B1 (ko) * 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
US7834027B2 (en) 2005-06-15 2010-11-16 Hetero Drugs Limited Gemifloxacin process and polymorphs
KR101364900B1 (ko) * 2006-03-07 2014-02-19 욱크하트 리미티드 벤조퀴놀리진-2-카르복실산의 프로드러그
WO2010001408A2 (en) * 2008-06-06 2010-01-07 Matrix Laboratories Ltd. Novel polymorphic forms of gemifloxacin mesylate
WO2010146594A1 (en) * 2009-06-16 2010-12-23 Hetero Research Foundation Novel polymorphs of gemifloxacin mesylate
EP2491921A1 (de) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Die Aufrechthaltung der wasserfreien Form von Gemifloxacin
EP3254681B1 (de) * 2012-02-27 2019-06-19 Bristol-Myers Squibb Company N-(5s,6s,9r)-5-amino-6-(2,3-difluorphenyl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridin-9-yl-4-(2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-1-yl)piperidin-1-carboxylatsalz
CZ2016104A3 (cs) * 2016-02-24 2017-09-06 Zentiva, K.S. Krystalické modifikace solí methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}fenyl)amino](fenyl)methyliden}-2-oxo-2,3-dihydro-1H-indol-6-karboxylátu a způsoby jejich přípravy

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR223983A1 (es) 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
ES512969A0 (es) 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
IN162769B (de) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US4931446A (en) * 1988-03-23 1990-06-05 Abbott Laboratories Antimicrobial for in-vitro diagnostic kits
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
PL166381B1 (pl) 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
US5276041A (en) 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives
WO1993025545A1 (en) 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
DE69509442T2 (de) * 1994-06-16 1999-09-02 Lg Chemical Ltd Chinolincarbonsäurederivate mit 7-(4-Amino-methyl-3-oxim)-pyrrolidin-Substituenten und Verfahren zu ihrer Herstellung
US5776944A (en) * 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
EP0787720B1 (de) 1994-10-20 2003-07-16 Wakunaga Seiyaku Kabushiki Kaisha Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
AU5260096A (en) 1995-01-30 1996-08-21 Wakunaga Seiyaku Kabushiki Kaisha Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agent containing the same as active ingredient
US5763454A (en) 1995-06-06 1998-06-09 Pfizer, Inc. Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
US20020032216A1 (en) * 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
KR100286874B1 (ko) * 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
MA24500A1 (fr) 1998-10-01
SK123699A3 (en) 2000-08-14
JP4781614B2 (ja) 2011-09-28
AP9901649A0 (en) 1999-09-30
BG63972B1 (bg) 2003-08-29
ZA982335B (en) 1999-11-23
DE69814378D1 (de) 2003-06-12
SI0981527T1 (en) 2003-10-31
UA56218C2 (uk) 2003-05-15
PT1179533E (pt) 2004-05-31
HU0600401D0 (en) 2006-07-28
AR012125A1 (es) 2000-09-27
US20150291585A1 (en) 2015-10-15
HUP0600401A3 (en) 2010-05-28
US20170253588A1 (en) 2017-09-07
KR100266499B1 (ko) 2000-12-01
ATE257836T1 (de) 2004-01-15
WO1998042705A1 (en) 1998-10-01
DK1179533T3 (da) 2004-05-03
NZ337748A (en) 2001-03-30
US20090182006A1 (en) 2009-07-16
OA11161A (en) 2003-04-25
EP1179533A3 (de) 2002-03-20
US20160264569A1 (en) 2016-09-15
IS7952A (is) 2005-07-21
DZ2448A1 (fr) 2003-01-11
HK1026698A1 (en) 2000-12-22
CA2283671C (en) 2003-09-16
US20080039488A1 (en) 2008-02-14
HU227536B1 (en) 2011-08-29
JP2009051851A (ja) 2009-03-12
US20110312987A1 (en) 2011-12-22
JP3759962B2 (ja) 2006-03-29
NO994595L (no) 1999-09-21
PE67999A1 (es) 1999-09-30
US20140187576A1 (en) 2014-07-03
ES2198697T3 (es) 2004-02-01
US20130065917A1 (en) 2013-03-14
AP1331A (en) 2004-11-26
AU6636698A (en) 1998-10-20
BR9808290A (pt) 2000-05-16
PT981527E (pt) 2003-09-30
ES2213669T3 (es) 2004-09-01
PL191815B1 (pl) 2006-07-31
EP1179533B1 (de) 2004-01-14
IL131812A (en) 2006-04-10
AU726634B2 (en) 2000-11-16
HUP0000728A2 (hu) 2000-09-28
IN188178B (de) 2002-08-31
NO994595D0 (no) 1999-09-21
JP2004002413A (ja) 2004-01-08
EA199900855A1 (ru) 2000-04-24
CZ288715B6 (cs) 2001-08-15
BG103750A (en) 2000-06-30
DE69821147D1 (de) 2004-02-19
EA001674B1 (ru) 2001-06-25
IS2093B (is) 2006-04-12
DE69821147T2 (de) 2004-11-11
EP1179533A2 (de) 2002-02-13
US20100240694A1 (en) 2010-09-23
SK284107B6 (sk) 2004-09-08
HUP0000728A3 (en) 2002-12-28
CN1251101A (zh) 2000-04-19
ID22681A (id) 1999-12-09
IS5181A (is) 1999-09-14
CA2283671A1 (en) 1998-10-01
TR199902313T2 (xx) 1999-12-21
HU225412B1 (en) 2006-11-28
DE69814378T2 (de) 2004-02-26
DK0981527T3 (da) 2003-09-01
PL335812A1 (en) 2000-05-22
KR19980080504A (ko) 1998-11-25
NO312515B1 (no) 2002-05-21
IS2095B (is) 2006-04-12
MY137653A (en) 2009-02-27
JP2000510484A (ja) 2000-08-15
EP0981527B1 (de) 2003-05-07
IL131812A0 (en) 2001-03-19
CZ328299A3 (cs) 2000-02-16
SI1179533T1 (en) 2004-04-30
EP0981527A1 (de) 2000-03-01
CN1131229C (zh) 2003-12-17
CZ288673B6 (cs) 2001-08-15
SA98181055B1 (ar) 2006-10-11
US7700617B2 (en) 2010-04-20

Similar Documents

Publication Publication Date Title
ATE239724T1 (de) Salz von naphthylidincarbonsäure-derivaten
DE69823016D1 (de) Wässrige lösungen von salicylsaure derivaten
TR199802106A3 (tr) Sübstitüe edilmis izokinolin-3-karbon asidi amidleri.
ATE248812T1 (de) Arylsulfonylhydroxamsäurederivate
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
DE69715801T2 (de) Granuläre Zusammensetzungen von E-pthalimido-Peroxyhexansäure
ATE196764T1 (de) Kristallform von 5-methylisoxazol-4-carbonsäure- (4-trifluormethyl)-anilid
EE200000241A (et) 8-metoksükinoloonkarboksüülhapete valmistamismeetod
FI941712A (fi) Heterosykliset iminobismetyleenibisfosfonihappojohdannaiset
IS5009A (is) 3-Alkoxýísoxazól-4-ýl setin 2-amínó karboxýlsýru efnasambönd
FI960634A0 (fi) Uusia kinolonikarboksyylihappojohdannaisia
DE69618045D1 (de) Clavulansäure Salz
NO996366L (no) Arylkarboksylsyre- og tetrazolderivater
FI941380A0 (fi) Heterosyklisesti substituoitujen fenyylietikkahappojohdannnaisten fenyyliglysiiniamidit
DE59807008D1 (de) Aluminiumsalze von alkylhydroxymethylphosphinsäuren
ATE420884T1 (de) Verbessertes fällungsverfahren von 7- aminocephalosporansäure
FI942403A0 (fi) Menetelmä orgaanisen hapon tai sen suolan valmistaMenetelmä orgaanisen hapon tai sen suolan valmistamiseksi miseksi
BR9610139A (pt) Derivado de ácido carboxílico
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
FI940133A (fi) Uudet nikotiinihappojohdannaiset
NO995841L (no) Fremgangsmåte for fremstilling av 3-(7-amidino-2-naftyl)-2- fenylpropionsyre-derivater
ATE244697T1 (de) Phenylester-derivate von alpha-aminosäuren
DE964848T1 (de) Preparation of alpha-amino carboxylic acid amides

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0981527

Country of ref document: EP